Table 1.
Clinical baseline characteristics of patients
| Variables | AMI (n=225) | AMID-N (n=21) | AMID-P (n=23) | AMID-F (n=23) |
|---|---|---|---|---|
| Sex (male/female) | 119/106 | 12/9 | 13/10 | 12/11 |
| Age (years) | 60.2±9.7 | 62.3±10.1 | 63.4±10.7 | 61.7±10.4 |
| Risk factors | ||||
| Smoking, n (%) | 72 (49) | 10 (50) | 12 (54) | 11 (48) |
| Family history of IHD, n (%) | 69 (47) | 9 (45) | 11 (48) | 12 (54) |
| Obesity, n (%) | 37 (25) | 5 (27) | 5 (24) | 5 (24) |
| Diabetes, n (%) | 43 (29) | 5 (26) | 6 (29) | 6 (29) |
| Hypertension, n (%) | 83 (56) | 12 (57) | 13 (57) | 12 (54) |
| Total cholesterol (mmol/L) | 4.29±0.69 | 4.20±0.74 | 4.26±0.75 | 4.23±0.72 |
| Triglyceride (mmol/L) | 2.23±2.26 | 2.36±2.58 | 2.33±2.36 | 2.35±2.37 |
| HDL-cholesterol (mmol/L) | 1.17±0.28 | 1.13±0.29 | 1.16±0.24 | 1.18±0.25 |
| LDL-cholesterol (mmol/L) | 3.48±2.09 | 3.57±2.17 | 3.46±2.08 | 3.49±2.19 |
| C-reactive protein (mg/L) | 5.25±7.16 | 5.15±8.23 | 5.26±7.98 | 5.17±7.66 |
| Laboratory assay | ||||
| Myoglobin (ng/mL) | 323.2±212.4 | 329.3±229.1 | 319±214.0 | 324±221.2 |
| Creatine kinase-MB (U/L) | 192.3±144.7 | 199.2±163.4 | 196±153.1 | 201±155.3 |
| Troponin I (ng/mL) | 15.4±14.39 | 14.9±15.03 | 14.7±14.34 | 14.1±13.74 |
| Lymphocyte count (109/L) | 2.2±1.2 | 2.1±0.8 | 2.3±1.3 | 2.2±1.2 |
| Number of lesions vessels | 1.4±0.7 | 1.6±0.6 | 1.5±0.9 | 1.5±0.9 |
| Concomitant therapy | ||||
| Aspirin, n (%) | 220 (98) | 21 (100) | 23 (100) | 22 (97) |
| Clopidogrel/ticagrelor, n (%) | 207 (92) | 20 (91) | 23 (100) | 23 (100) |
| Statins, n (%) | 225 (100) | 22 (100) | 23 (100) | 23 (100) |
| Beta-blockers, n (%) | 175 (78) | 16 (76) | 17 (74) | 18 (78) |
| ACE inhibitors, n (%) | 60 (27) | 6 (29) | 7 (30) | 8 (34) |
| Nitrates, n (%) | 180 (80) | 16 (76) | 18 (78) | 17 (74) |
| Calcium blockers, n (%) | 56 (25) | 5 (24) | 6 (26) | 7 (30) |
| PCI + stent, n (%) | 207 (92) | 20 (95) | 21 (91) | 21 (91) |
Note: Data was expressed as mean ± SD.
Abbreviations: ACE, angiotensin-converting enzyme; AMI, acute myocardial infarction; AMID, acute myocardial infarction with depression; F, fluoxetine; HDL, high density lipoprotein; IHD, ischemic heart disease; LDL, low density lipoprotein; N, non-antidepressant; P, paroxetine; PCI, percutaneous coronary intervention; SD, standard deviation.